{"schema_version":"1","generated_at":"2026-10-30T14:52:53.006Z","data_as_of":null,"url":"https://www.findmykol.com/kol/reshma-mahtani","json_url":"https://www.findmykol.com/kol/reshma-mahtani/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"reshma-mahtani","name":"Reshma Mahtani","credential":"DO","specialty":"Medical Oncology","specialty_raw":"Medical Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"institution":"Baptist Hospital of Miami","institution_url":"https://www.findmykol.com/institution/baptist-hospital-of-miami","city":"Plantation","state":"FL","region":{"label":"Southeast","url":"https://www.findmykol.com/region/southeast"}},"identifiers":{"npi":"1902091218","orcid":"0000-0002-7711-8627","openalex":"A5000862048"},"summary":"Reshma Mahtani is an Oncology physician affiliated with Baptist Hospital of Miami. OpenAlex indexes 193 publications with 2,662 citations (h-index 21); ClinicalTrials.gov lists 2 registered studies matched to this name.","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"works_count":193,"cited_by_count":2662,"h_index":21,"latest_activity_year":2025,"source":"works"},"trials":{"count":2,"shown":2,"withheld":0,"matched_by":"investigator name, confirmed against institution and geography","rows":[{"nct":"NCT06263543","title":"Sequencing Antibody Drug Conjugates in ER+/HER2 LOW/ULTRA LOW MBC","phase":"PHASE2","status":"RECRUITING","role":"Overall official","sponsor":"Reshma L. Mahtani, D.O.","source_url":"https://clinicaltrials.gov/study/NCT06263543","trial_url":"https://www.findmykol.com/trial/NCT06263543"},{"nct":"NCT02658084","title":"Vinorelbine With Trastuzumab Emtansine in Pre-Treated HER2-Positive Metastatic Breast Cancer","phase":"PHASE1/PHASE2","status":"TERMINATED","role":"Overall official","sponsor":"University of Miami","source_url":"https://clinicaltrials.gov/study/NCT02658084","trial_url":"https://www.findmykol.com/trial/NCT02658084"}],"source":"trials"},"payments":{"company_count":25,"program_years":{"first":2021,"last":null},"rows_total":59,"shown":3,"withheld":56,"rows":[{"payer":"Gilead Sciences, Inc.","program_year":2025,"amount_usd":47470.61,"payment_count":30,"source_url":"https://openpaymentsdata.cms.gov/search?query=1902091218"},{"payer":"AstraZeneca Pharmaceuticals LP","program_year":2025,"amount_usd":31391.96,"payment_count":22,"source_url":"https://openpaymentsdata.cms.gov/search?query=1902091218"},{"payer":"PFIZER INC.","program_year":2025,"amount_usd":27682.66,"payment_count":17,"source_url":"https://openpaymentsdata.cms.gov/search?query=1902091218"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1902091218","source":"payments"},"publications":{"total":50,"shown":5,"withheld":45,"matched_by":"OpenAlex author record","recent":[{"title":"Multicenter retrospective cohort study of the sequential use of the antibody-drug conjugates (ADCs) trastuzumab deruxtecan (T-DXd) and sacituzumab govitecan (SG) in patients with HER2-low metastatic breast cancer (MBC)","year":2025,"journal":"npj Breast Cancer","source_url":"https://doi.org/10.1038/s41523-025-00748-5","status":"verified"},{"title":"Patient-reported outcomes from DESTINY-Breast04: trastuzumab deruxtecan versus physician’s choice of chemotherapy in patients with HER2-low mBC","year":2025,"journal":"The Oncologist","source_url":"https://doi.org/10.1093/oncolo/oyaf048","status":"verified"},{"title":"Treatment rechallenge after trastuzumab-deruxtecan–related interstitial lung disease: A multi-institution cohort study.","year":2025,"journal":"Journal of Clinical Oncology","source_url":"https://doi.org/10.1200/jco.2025.43.16_suppl.1015","status":"verified"},{"title":"Mechanisms of resistance to trastuzumab deruxtecan in breast cancer elucidated by multi-omic molecular profiling","year":2025,"journal":"npj Breast Cancer","source_url":"https://doi.org/10.1038/s41523-025-00868-y","status":"verified"},{"title":"Abstract PS13-09: Mechanisms of Resistance to Trastuzumab Deruxtecan in Breast Cancer Elucidated by Multi-omic Molecular Profiling","year":2025,"journal":"Clinical Cancer Research","source_url":"https://doi.org/10.1158/1557-3265.sabcs24-ps13-09","status":"verified"}],"source":"works"},"contact":{"address_1":"1228 S PINE ISLAND RD STE 410","city":"Plantation","state":"FL","zip":"333244583","phone":"954-837-1490","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1902091218","source":"identity"},"similar":[{"name":"Lyle Feinstein","slug":"lyle-feinstein","institution":"Baptist Hospital of Miami","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/lyle-feinstein","json_url":"https://www.findmykol.com/kol/lyle-feinstein/profile.json"},{"name":"Horacio Asbun","slug":"horacio-asbun","institution":"Baptist Hospital of Miami","specialty":"Surgical Oncology","url":"https://www.findmykol.com/kol/horacio-asbun","json_url":"https://www.findmykol.com/kol/horacio-asbun/profile.json"},{"name":"Ricardo Cury","slug":"ricardo-cury","institution":"Baptist Hospital of Miami","specialty":"Diagnostic Radiology","url":"https://www.findmykol.com/kol/ricardo-cury","json_url":"https://www.findmykol.com/kol/ricardo-cury/profile.json"},{"name":"Atulya Khosla","slug":"atulya-khosla","institution":"Baptist Hospital of Miami","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/atulya-khosla","json_url":"https://www.findmykol.com/kol/atulya-khosla/profile.json"},{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"},{"name":"Larry Norton","slug":"larry-norton","institution":"Memorial Sloan Kettering Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/larry-norton","json_url":"https://www.findmykol.com/kol/larry-norton/profile.json"}],"coverage":{"note":"A basic record from the physician directory. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"payments":56,"publications":45}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2021-11-24","provider_certified":"2021-11-24","collected_at":"2026-10-27T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"}},"methodology_url":"https://www.findmykol.com/about#methodology"}